Pharmaceutical Care
Learning Objectives
By the end of this page, you should be able to:
- State the Hepler and Strand definition of pharmaceutical care and explain what makes it patient-centered rather than product-centered
- Identify the five core principles guiding pharmaceutical care practice
- Distinguish between drug-related problems (DRPs) and general medication errors
- Apply a structured pharmaceutical care process (assess, plan, implement, monitor) to a patient case
- Explain how pharmaceutical care differs from simple dispensing and from clinical pharmacy as a broader category
- Identify barriers that commonly prevent pharmacists from delivering full pharmaceutical care
Quick Answer
Pharmaceutical care is a philosophy and practice model in which the pharmacist takes direct, ongoing responsibility for a patient's medication-related needs, aiming to achieve specific, measurable therapeutic outcomes that improve the patient's quality of life — not merely to supply the correct drug. It matters because it reframes the pharmacist's job: instead of asking "did I dispense this correctly?" the pharmacist asks "is this patient's overall drug therapy actually working, safe, and appropriate for their life?" This shift, formalized by Hepler and Strand in 1990, moved pharmacy practice from a product-focused profession toward a patient-outcome-focused one, and it underlies most of the clinical services pharmacists now provide, from medication therapy management to chronic disease monitoring.
The Hepler and Strand Definition
The foundational definition states that pharmaceutical care is "the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life." Three words in that definition do most of the work: responsible (the pharmacist accepts direct accountability, not just a supporting role), definite outcomes (care is judged by whether specific therapeutic goals are actually met, not by whether a product was correctly handed over), and quality of life (the ultimate measure is the patient's lived experience, not a lab value in isolation). This reframing matters because it shifted the professional identity of pharmacy: a pharmacist practicing pharmaceutical care is accountable for whether the patient's blood pressure is actually controlled, not just for whether the antihypertensive was dispensed correctly.
The Five Core Principles
- Patient-centered care — The patient's needs, preferences, and quality of life are the starting point, not the drug or the prescription.
- Individualized care — Therapy is tailored to the specific patient's physiology, circumstances, and goals, not applied as a one-size-fits-all protocol.
- Continuous care — Pharmaceutical care doesn't end at the point of dispensing; it involves ongoing follow-up and adjustment over the full course of therapy.
- Outcome-oriented care — Success is measured by whether the intended therapeutic goal (controlled blood pressure, resolved infection, managed pain) is actually achieved.
- Collaborative practice — The pharmacist works actively with physicians, nurses, and the patient themselves, rather than operating in isolation from the rest of the care team.
These principles work together: individualized, patient-centered goals are meaningless without continuous follow-up to check whether they're being met, and outcome measurement is meaningless without collaboration to actually act on what's found.
Drug-Related Problems (DRPs)
The systematic assessment step of pharmaceutical care centers on identifying drug-related problems — any circumstance involving drug therapy that actually or potentially interferes with achieving the desired therapeutic outcome. Common categories include: an untreated indication (a condition that needs medication but has none), an unnecessary drug therapy (no valid current indication), the wrong drug for the indication, too high or too low a dose, an adverse drug reaction, a drug interaction, and non-adherence. Framing these issues as "drug-related problems" rather than simply "medication errors" is deliberate — a DRP can exist even when no one made a technical mistake (e.g., a correctly prescribed and correctly dispensed drug that the patient simply isn't taking due to cost or side effects is still a DRP requiring pharmacist intervention).
The Pharmaceutical Care Process
Delivering pharmaceutical care follows a structured, repeatable cycle, closely related to the clinical pharmacotherapy workup used in clinical pharmacy:
- Assess — Gather the patient's full medication history, current problems, and goals; identify any drug-related problems.
- Plan — Establish specific, individualized, measurable therapeutic goals (e.g., "blood pressure below 130/80 within 8 weeks" rather than a vague "control blood pressure").
- Implement — Initiate, adjust, or discontinue therapy as needed, and counsel the patient on the plan.
- Monitor and follow up — Track whether the goal is actually being achieved, and cycle back to reassessment if it isn't.
This cycle is what distinguishes pharmaceutical care from a single, isolated counseling interaction — it's an ongoing relationship with accountability for the outcome, not a one-time information transfer.
Pharmaceutical Care vs. Dispensing vs. Clinical Pharmacy
These three terms are related but not identical, and students frequently conflate them. Dispensing is the mechanical/legal act of supplying medication safely against a valid prescription. Clinical pharmacy is the broader professional domain of applying pharmacotherapy knowledge to patient care (which can happen in a hospital, clinic, or community setting). Pharmaceutical care is a specific philosophy and accountability model within clinical pharmacy practice — it's the "why" and "how the pharmacist is responsible," rather than a separate setting or skill set. A pharmacist can dispense correctly without practicing pharmaceutical care (if they never verify the outcome), and a pharmacist can practice pharmaceutical care in a community pharmacy just as much as in a hospital.
Real-World Example
A 65-year-old patient with hypertension is assessed by a pharmacist providing pharmaceutical care. Assessment reveals the patient has been prescribed an appropriate antihypertensive, but blood pressure readings over the past two months remain above target. Rather than assuming the drug isn't working, the pharmacist investigates further and discovers the patient has been skipping doses because of a persistent dry cough (a known class effect of ACE inhibitors) that they didn't think to mention because they assumed it was unrelated. The plan is revised: switch to an angiotensin receptor blocker (which doesn't share this side effect), set a specific new goal (blood pressure below 130/80 within 8 weeks), and schedule a follow-up call in two weeks to confirm both adherence and blood pressure trend. This case shows pharmaceutical care's real distinguishing feature: the pharmacist didn't stop at "the prescription was filled correctly" — they took responsibility for the actual outcome and kept investigating until they found the real drug-related problem (undisclosed non-adherence due to a side effect).
Barriers to Full Pharmaceutical Care
In practice, several barriers limit how fully pharmacists can implement this model: time pressure and high dispensing volume that leave little room for the ongoing follow-up the model requires; lack of remuneration structures that pay pharmacists specifically for cognitive/monitoring services rather than only for dispensing volume; limited access to patient clinical data (labs, full medical history) outside hospital settings; and workflow/technology systems not designed to support longitudinal tracking of therapeutic goals. Recognizing these barriers matters because pharmaceutical care is often taught as an idealized model without acknowledging that delivering it fully requires systemic support, not just individual pharmacist willingness.
Why It Matters
Pharmaceutical care reframed the entire justification for the pharmacy profession — from "the person who correctly supplies drugs" to "the professional accountable for whether drug therapy actually achieves its intended health outcome." That shift underlies the expansion of pharmacist roles into medication therapy management, chronic disease monitoring, and collaborative prescribing seen across modern pharmacy practice.
Key Terms
| Term | Definition | Related Concept |
|---|---|---|
| Pharmaceutical care | Responsible provision of drug therapy to achieve definite outcomes improving quality of life | Hepler and Strand definition |
| Drug-related problem (DRP) | Any circumstance involving drug therapy that interferes with achieving a desired therapeutic outcome | Assessment step |
| Outcome-oriented care | Principle that success is measured by achievement of a specific therapeutic goal | Continuous monitoring |
| Individualized care | Tailoring therapy to a specific patient's needs rather than a generic protocol | Patient-centered care |
| Medication therapy management (MTM) | A structured clinical service applying pharmaceutical care principles to a patient's full regimen | Pharmaceutical care in practice |
| Non-adherence | Failure to take medication as prescribed, a common and often underdiagnosed drug-related problem | Adherence counseling |
| Collaborative practice | Active pharmacist engagement with physicians, nurses, and patients in shared decision-making | Interprofessional care |
| Therapeutic goal | A specific, measurable target for a patient's treatment (e.g., blood pressure below 130/80) | Planning step |
| Quality of life | The patient's overall wellbeing and functioning, the ultimate outcome measure in pharmaceutical care | Hepler and Strand definition |
| Follow-up / monitoring | Ongoing tracking of whether a therapeutic goal is being achieved over time | Continuous care principle |
Common Mistakes
Misconception: Pharmaceutical care is just a more formal term for good dispensing and counseling. Why it's wrong: Dispensing and counseling are one-time transactional interactions; pharmaceutical care is defined by ongoing accountability for whether the patient's actual therapeutic outcome is achieved, requiring continuous monitoring and follow-up, not a single well-executed interaction. Correct understanding: Pharmaceutical care requires a closed-loop process — assess, plan, implement, and monitor — where the pharmacist stays accountable until the specific therapeutic goal is confirmed as met or the plan is revised.
Misconception: A drug-related problem only exists when someone made a clear mistake, like a wrong dose or a missed interaction check. Why it's wrong: DRPs include situations with no technical error at all — a correctly prescribed, correctly dispensed drug that a patient isn't taking due to cost, side effects, or forgetfulness is still a drug-related problem preventing the intended outcome. Correct understanding: A DRP is defined by its effect on achieving the therapeutic outcome, not by whether a specific person made an identifiable mistake — non-adherence and undiagnosed side effects count just as much as dosing errors.
Misconception: Pharmaceutical care can only be delivered in a hospital with full access to a patient's chart. Why it's wrong: While hospital settings offer richer clinical data, community pharmacists deliver pharmaceutical care every time they follow up on a chronic condition, adjust counseling based on reported side effects, or track adherence over multiple visits — the defining feature is the ongoing accountability model, not the practice setting. Correct understanding: Pharmaceutical care can and does occur in community, ambulatory, and hospital settings alike; what defines it is the philosophy and process, not the location.
Comparison and Connections
| Feature | Dispensing | Pharmaceutical Care |
|---|---|---|
| Time horizon | Single transaction | Ongoing, continuous |
| Success measure | Correct product supplied safely | Specific therapeutic outcome achieved |
| Accountability | For the accuracy of this transaction | For the patient's overall drug therapy outcome |
| Typical activity | Verify, prepare, label, counsel once | Assess, plan, implement, monitor, follow up |
| Relationship to clinical pharmacy | A component task within it | A philosophy/accountability model guiding it |
Practice Questions
Recall
-
State the Hepler and Strand definition of pharmaceutical care. Answer guidance: "The responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life."
-
List the five core principles of pharmaceutical care. Answer guidance: Patient-centered care, individualized care, continuous care, outcome-oriented care, and collaborative practice.
Understanding
-
Explain why non-adherence is classified as a drug-related problem even though no one made a clinical or dispensing error. Answer guidance: A DRP is defined by whether it interferes with achieving the desired therapeutic outcome, not by whether a specific mistake was made. A patient who isn't taking a correctly prescribed, correctly dispensed drug still won't achieve the intended outcome, so it counts as a DRP requiring pharmacist intervention (investigating and addressing the reason for non-adherence).
-
Why does pharmaceutical care require a continuous process (assess-plan-implement-monitor) rather than a single well-executed counseling session? Answer guidance: A single session can confirm the patient understood instructions at that moment, but it cannot confirm the therapeutic goal is actually being achieved over time, or catch new problems (side effects, changing adherence, new interacting medications) that emerge later — continuous monitoring is what allows the pharmacist to detect and respond to these changes.
Application
-
A patient with type 2 diabetes has an HbA1c above target despite being on an appropriate, correctly dosed medication for six months. Using the pharmaceutical care process, outline the next steps. Answer guidance: Reassess (why is the goal not met — adherence, diet, dose adequacy, disease progression, absorption issues), then revise the plan with a specific new goal and timeline, implement any needed change (dose adjustment, add therapy, address adherence barriers, refer for further workup), and schedule follow-up monitoring to confirm the revised plan is working.
-
A pharmacist providing pharmaceutical care to an elderly patient on eight medications identifies one drug with no clear current indication in the patient's history. What DRP category does this represent, and what should the pharmacist do? Answer guidance: This represents "unnecessary drug therapy" (a drug without a valid current indication) — the pharmacist should investigate the original reason for the drug (chart review or contacting the prescriber), and if truly unnecessary, recommend deprescribing to the prescriber, since unnecessary medications increase interaction risk and cost without benefit.
Analysis
-
A pharmacy wants to implement full pharmaceutical care for its chronic disease patients but currently only has capacity for standard dispensing-level interactions. Analyze the systemic barriers involved and propose realistic first steps. Answer guidance: Barriers likely include time/staffing constraints, lack of remuneration for cognitive services beyond dispensing, and no existing system for tracking patient goals over time. Realistic first steps could include starting with a small, high-risk patient subset (e.g., poorly controlled diabetics), using a simple tracking tool for goals and follow-up dates, and seeking reimbursement pathways (like MTM billing codes, where available) rather than attempting full-scale implementation immediately.
-
Compare how "success" would be measured for the same antihypertensive prescription under a purely dispensing-focused model versus a pharmaceutical care model. What does each model miss if used alone? Answer guidance: Under a dispensing-focused model, success is "the correct drug, dose, and quantity were supplied against a valid prescription" — this misses whether the patient is actually taking it, tolerating it, or achieving blood pressure control. Under a pharmaceutical care model, success is "the patient's blood pressure reaches and stays at target" — this requires more resources and follow-up infrastructure than pure dispensing, so a system relying only on this model without addressing capacity/reimbursement barriers may fail to deliver it consistently. In practice, both are necessary: safe dispensing is the foundation the pharmaceutical care process builds upon.
FAQ
Is pharmaceutical care the same as medication therapy management (MTM)? MTM is a specific, often billable clinical service (a structured medication review, typically for patients with multiple chronic conditions or multiple medications) that operationalizes pharmaceutical care principles. Pharmaceutical care is the broader underlying philosophy; MTM is one concrete way of delivering it in practice.
Can a drug-related problem exist even if the patient feels fine? Yes — a patient can feel fine while still having an unrecognized problem, such as a subtherapeutic dose that isn't yet causing noticeable symptoms, or an unnecessary drug quietly increasing interaction risk. This is exactly why systematic, goal-based monitoring (checking objective markers like blood pressure or lab values) matters more than relying on how the patient subjectively feels.
How is a therapeutic goal made "specific and measurable" rather than vague? Instead of a vague goal like "manage the patient's blood pressure," a specific goal states a target value and timeframe, such as "blood pressure below 130/80 mmHg within 8 weeks." This makes it possible to objectively check at follow-up whether the goal was actually achieved, rather than relying on a subjective sense of improvement.
Why did pharmacy practice need a formal shift toward pharmaceutical care if pharmacists were already counseling patients? Before the Hepler and Strand framework, counseling was often an optional, inconsistently applied add-on to dispensing, with no formal accountability for whether it actually led to a better outcome. Pharmaceutical care formalized outcome accountability as the pharmacist's defined professional responsibility, which helped justify expanded clinical roles, reimbursement models, and training standards across the profession.
Does pharmaceutical care apply to short-term, acute treatments, or only chronic disease management? It applies to both, though the process looks different. For a short antibiotic course, the "continuous care" element might simply be a brief follow-up call to confirm resolution and completion of the course; for chronic disease, it involves ongoing, longer-term monitoring cycles. The core principle — accountability for the actual outcome, not just correct dispensing — applies regardless of treatment duration.
Quick Revision
- Hepler and Strand (1990) defined pharmaceutical care as responsible provision of drug therapy to achieve definite outcomes improving quality of life
- Five principles: patient-centered, individualized, continuous, outcome-oriented, collaborative
- A drug-related problem (DRP) is any drug therapy circumstance interfering with the intended outcome — including non-adherence, not just technical errors
- The pharmaceutical care process: assess, plan, implement, monitor — a repeating cycle, not a one-time interaction
- Pharmaceutical care is a philosophy/accountability model, distinct from dispensing (a task) and broader than clinical pharmacy (a domain)
- Success is measured by whether a specific, measurable therapeutic goal is achieved, not just whether counseling occurred
- Non-adherence and unnecessary drug therapy are DRP categories even without any dispensing mistake
- Pharmaceutical care can be delivered in community, ambulatory, or hospital settings — the location doesn't define it
- Common barriers: time pressure, lack of dedicated reimbursement, limited data access outside hospitals
- Medication therapy management (MTM) is a concrete clinical service operationalizing pharmaceutical care principles
Related Topics
Prerequisites: Clinical Pharmacy and Therapeutics; Community Pharmacy; Hospital Pharmacy
Related Topics: Clinical Pharmacy and Therapeutics; Pharmacy Management; Health Policy and Public Health
Next Topics: Health Policy and Public Health; Pharmacy Law and Ethics; Pharmacoeconomics